A 5-HT6 Antagonist as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer's Disease: Idalopirdine in Phase III von Atri, Alireza, MD, PhD, Tong, Gary, MD, PhD, Isojarvi, Jouko, MD, PhD, Odergren, Tomas, MD, PhD

Volltext

Cerebral and cerebellar activation in correlation to the action-induced dystonia in Writer's cramp von Odergren, Tomas, Stone-Elander, Sharon, Ingvar, Martin

Volltext

Early impairment in consciousness predicts mortality after hemispheric ischemic stroke von CUCCHIARA, Brett L, KASNER, Scott E, WOLK, David A, LYDEN, Patrick D, KNAPPERTZ, Volker A, ASHWOOD, Tim, ODERGREN, NORDLUND, Anders

Volltext

Idalopirdine, a 5-HT6 antagonist in Phase III development as adjunctive therapy to cholinesterase inhibitors in patients with mild-to-moderate Alzheimer’s disease: the observed cas... von Cummings, Jeffrey, Windfeld, Kristian, Odergren, Tomas

Volltext

Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease von Johannesson, Malin, Sahlin, Charlotte, Söderberg, Linda, Basun, Hans, Fälting, Johanna, Möller, Christer, Zachrisson, Olof, Sunnemark, Dan, Svensson, Anne, Odergren, Tomas, Lannfelt, Lars

Volltext

Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti‐α‐Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults... von Boström, Emma, Bachhav, Sagar S., Xiong, Hao, Zadikoff, Cindy, Li, Qingbo, Cohen, Eric, Dreher, Ingeborg, Torrång, Anna, Osswald, Gunilla, Moge, Mikael, Appelkvist, Paulina, Fälting, Johanna, Odergren, Tomas

Volltext

Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains von Gkanatsiou, Eleni, Sahlin, Charlotte, Portelius, Erik, Johannesson, Malin, Söderberg, Linda, Fälting, Johanna, Basun, Hans, Möller, Christer, Odergren, Tomas, Zetterberg, Henrik, Blennow, Kaj, Lannfelt, Lars, Brinkmalm, Gunnar

Volltext

A 5-HT6 Antagonist as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer’s Disease: Idalopirdine in Phase III (PL02.006) von Atri, Alireza, Tong, Gary, Isojarvi, Jouko, Odergren, Tomas

Volltext

Poster Number: NR 16 - A 5-HT6 Antagonist as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer's Disease: Idalopirdine in Phase III von Atri, Alireza, Tong, Gary, Isojarvi, Jouko, Odergren, Tomas

Volltext

Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains von Gkanatsiou, Eleni, Sahlin, Charlotte, Portelius, Erik, Johannesson, Malin, Söderberg, Linda, Fälting, Johanna, Basun, Hans, Möller, Christer, Odergren, Tomas, Zetterberg, Henrik, Blennow, Kaj, Lannfelt, Lars, Brinkmalm, Gunnar

Volltext

Characterization of monomeric and soluble aggregated Aβ in Down’s syndrome and Alzheimer’s disease brains: Human neuropathology/amyloid von Gkanatsiou, Eleni, Sahlin, Charlotte, Portelius, Erik, Johannesson, Malin, Söderberg, Linda, Fälting, Johanna, Basun, Hans, Möller, Christer, Odergren, Tomas, Zetterberg, Henrik, Blennow, Kaj, Lannfelt, Lars, Brinkmalm, Gunnar

Volltext

Animal models of stroke: do they have value for discovering neuroprotective agents? von Richard Green, A., Odergren, Tomas, Ashwood, Tim

Volltext

Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force von Soto, Maria, Rosenberg, P., Ballard, C., Vellas, B., Miller, D., Gauthier, S., Carrillo, M. C., Lyketsos, C., Ismail, Z., Abushakra, Susan, Afshar, Mohammad, Agus, Sam, Aiden, Paul, Alam, John, Algeciras-Schimnich, Alicia, Andrieu, Sandrine, Baruch, Amos, Bateman, Randall, Batrla, Richard, Baudler, Monika, Bell, Joanne, Bittner, Tobias, Bozeat, Sasha, Braunstein, Joel, Brooks, Dawn, Brooks, Tricia, Bullain, Szofia, Burmeister, Jan, Carrillo, Maria, Cho, Min, Collins, Emily, Cook, Gavin, Dague, Chris, De Santi, Susan, Doody, Rachelle, Dunn, Billy, Egan, Michael, Eriksson, Sven, Fagan, Tom, Ferrell, Phyllis, Gallagher, Michela, Grönblad, Anna-Kaija, Hains, Avis, Hampel, Harald, Hansson, Oskar, Hefting, Nanco, Hendrix, Suzanne, Ho, Carole, Hu, Helen, Jones, Daryl, Kinney, Gene, Kinnon, Paul, Kurzman, Ricky, Lannfelt, Lars, Lawson, John, LeBastard, Nathalie, Legrand, Valérie, Lewandowski, Nicole, Lim, Carine, Masterman, Donna, Masters, Colin, Lu, Ming, Molinuevo, José Luis, Monteiro, Cecilia, Navia, Bradford, Odergren, Tomas, Osswald, Gunilla, Penny, Lewis, Pontecorvo, Michael, Porsteinsson, Anton, Rabe, Christine, Raman, Rema, Respondek, Gesine, Reyderman, Larisa, Rogers, Sharon, Rosenberg, Paul, Rosenzweig-Lipson, Sharon, Roskey, Mark, Carrie, Rubel, Saad, Ziad, Salloway, Stephen, Schindler, Rachel, Selkoe, Dennis, Shulman, Melanie, Sims, John, Sink, Kaycee, Sipe, Lisa, Skovronsky, Daniel, Somers, Elizabeth, Streffer, Johannes, Such, Pedro, Suhy, Joyce, Toloue, Masoud, Touchon, Jacques, Vandijck, Manu, Weiner, Michael, White, Anne, Wilson, David, Zago, Wagner, Zhou, Jin

Volltext

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force von Angioni, D., Hansson, O., Bateman, R. J., Rabe, C., Toloue, M., Braunstein, J. B., Agus, S., Sims, J. R., Bittner, T., Carrillo, M. C., Fillit, H., Masters, C. L., Salloway, S., Aisen, P., Weiner, M., Vellas, B., Gauthier, S., Abushakra, Susan, Afshar, Mohammad, Alam, John, Algeciras-Schimnich, Alicia, Andrieu, Sandrine, Ballard, Clive, Baruch, Amos, Batrla, Richard, Baudler, Monika, Bell, Joanne, Bozeat, Sasha, Brooks, Dawn, Brooks, Tricia, Bullain, Szofia, Burmeister, Jan, Cho, Min, Collins, Emily, Cook, Gavin, Cummings, Jeffrey, Dague, Chris, De Santi, Susan, Doody, Rachelle, Dunn, Billy, Egan, Michael, Eriksson, Sven, Esquivel, Rianne, Fagan, Tom, Ferrell, Phyllis, Gallagher, Michela, Grönblad, Anna-Kaija, Hains, Avis, Hampel, Harald, Hefting, Nanco, Hendrix, Suzanne, Ho, Carole, Hu, Helen, Ismail, Zahinoor, Jones, Daryl, Kinney, Gene, Kinnon, Paul, Kurzman, Ricky, Lannfelt, Lars, Lawson, John, LeBastard, Nathalie, Lewandowski, Nicole, Lim, Carine, Lyketsos, Costantine, Masterman, Donna, Lu, Ming, Mintun, Mark, Molinuevo, José Luis, Monteiro, Cecilia, Navia, Bradford, Odergren, Tomas, Osswald, Gunilla, Penny, Lewis, Pontecorvo, Michael, Porsteinsson, Anton, Raman, Rema, Respondek, Gesine, Reyderman, Larisa, Rogers, Sharon, Rosenberg, Paul, Rosenzweig-Lipson, Sharon, Roskey, Mark, Saad, Ziad, Schindler, Rachel, Selkoe, Dennis, Shulman, Melanie, Sink, Kaycee, Sipe, Lisa, Skovronsky, Daniel, Somers, Elizabeth, Soto, Maria, Streffer, Johannes, Such, Pedro, Suhy, Joyce, Touchon, Jacques, Vandijck, Manu, White, Anne, Wilson, David, Zago, Wagner, Zhou, Jin

Volltext

Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059 von Green, A Richard, Ashwood, Tim, Odergren, Tomas, Jackson, David M

Volltext

Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force von Angioni, D., Cummings, J., Lansdall, C. J., Sampaio, C., Gauthier, S., Cohen, S., Petersen, R. C., Rentz, D. M., Wessels, A. M., Hendrix, S. B., Jessen, F., Carrillo, M. C., Doody, R. S., Irizarry, M., Andrews, J. S., Vellas, B., Aisen, P., Andrieu, Sandrine, Bateman, Randall, Batrla, Richard, Bell, Joanne, Bosson, Oskar, Brooks, Dawn, Haeberlein, Samantha Budd, Cho, Min, Crisitello, Darrin, Dangond, Fernando, de Santi, Susan, Dennehy, Ellen, Dhadda, Shobha, Dhillon, Harjeet, Dunn, Billy, Egan, Michael, Elwood, Fiona, Eriksson, Sven, Fillit, Howard, Gallagher, Diana, Granda, Carlos, Greeley, David, Gronblad, Anna-Kaija, Hampel, Harald, Hawthorne, Paul, Henley, David, Herring, Joe, Hersch, Steve, Holt, Bill, Jones, Daryl, Kahl, Anja, Kinney, Gene, Kolb, Hartmuth, Kramer, Lynn, Kulic, Luka, Kumar, Sanjay, Lannfelt, Lars, Lawson, John, Legrand, Valérie, Lenington, Rachel, Longo, Frank, Matthews, Brandy, Masterman, Donna, McLinden, Kristina, Mikels, Sarah, Miller, Michael, Monteiro, Cecilia, Murphy, Jennifer, Odergren, Tomas, Osswald, Gunilla, Parnas, Laura, Patru, Maria-Magdalena, Prazma, Charlene, Raman, Rema, Reyderman, Larisa, Rogers, Sharon, Roman, Lise, Romano, Gary, Roskey, Mark, Rubino, Ivana, Ryan, Laurie, Salloway, Stephen, Schindler, Rachel, Schneider, Lon, Scott, David, Sims, John, Soto, Marion, Steukers, Lennert, Stoops, Erik, Strittmatter, Stephen, Tahami, Amir, Tariot, Gilles, Toloue, Masoud, Touchon, Jacques, Vanmechelen, Eugeen, Walt, Len, Weiner, Michael, White, Anne, Wiesel, Iris, Wilson, David, Yarenis, Lisa, Zago, Wagner, Zhou, Jin

Volltext

Response to Letter by Proctor and Tamborello von Lees, Kennedy R., Ashwood, Tim, Odergren, Tomas

Volltext

The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada von Lyden, Patrick D., Ashwood, Timothy, Claesson, Lennart, Odergren, Tomas, Friday, Gary H., Martin-Munley, Sarah

Volltext

The Clomethiazole Acute Stroke Study in hemorrhagic stroke (Class-H): Final results von Lyden, Patrick D., Shuaib, Ashfaq, Ng, Ken, Atkinson, Richard, Ashwood, Timothy, Nordlund, Anders, Odergren, Tomas

Volltext

Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia von ANSVED, T, ODERGREN, T, BORG, K

Volltext